PAUL STAMER: Open Payments
NPI 1700889615 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$171 in 10 payments from 6 companies in 2025. Trend: 2023 $200 · 2024 $204 · 2025 $171
Food & beverage: $171
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Abbott Laboratories | 2 | $37 |
| ABBVIE INC. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Amgen Inc. | 1 | $17 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
Products named: AIRSUPRA, FREESTYLE LIBRE 3, VRAYLAR, Kerendia, OTEZLA, ZENPEP.
Industry payments across AZ — which companies pay providers there.
